CS243486B2 - Method of new pyrimidine derivatives production - Google Patents

Method of new pyrimidine derivatives production Download PDF

Info

Publication number
CS243486B2
CS243486B2 CS843255A CS325584A CS243486B2 CS 243486 B2 CS243486 B2 CS 243486B2 CS 843255 A CS843255 A CS 843255A CS 325584 A CS325584 A CS 325584A CS 243486 B2 CS243486 B2 CS 243486B2
Authority
CS
Czechoslovakia
Prior art keywords
formula
oder
und
methylene
alkyl
Prior art date
Application number
CS843255A
Other languages
Czech (cs)
English (en)
Other versions
CS325584A2 (en
Inventor
Ado Kaiser
Frank Kienzle
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of CS325584A2 publication Critical patent/CS325584A2/cs
Publication of CS243486B2 publication Critical patent/CS243486B2/cs

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/60Three or more oxygen or sulfur atoms
    • C07D239/62Barbituric acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/12Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
    • C07D491/14Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
CS843255A 1983-05-05 1984-05-02 Method of new pyrimidine derivatives production CS243486B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH244283 1983-05-05
CH139284 1984-03-20

Publications (2)

Publication Number Publication Date
CS325584A2 CS325584A2 (en) 1985-08-15
CS243486B2 true CS243486B2 (en) 1986-06-12

Family

ID=25687524

Family Applications (1)

Application Number Title Priority Date Filing Date
CS843255A CS243486B2 (en) 1983-05-05 1984-05-02 Method of new pyrimidine derivatives production

Country Status (16)

Country Link
US (1) US4581172A (fr)
EP (1) EP0124893A3 (fr)
AU (1) AU2751084A (fr)
CA (1) CA1237429A (fr)
CS (1) CS243486B2 (fr)
DK (1) DK198784A (fr)
ES (1) ES8505369A1 (fr)
FI (1) FI841619A7 (fr)
HU (1) HUT34025A (fr)
IL (1) IL71711A (fr)
MC (1) MC1600A1 (fr)
NO (1) NO841780L (fr)
NZ (1) NZ207981A (fr)
PH (1) PH19219A (fr)
PT (1) PT78549B (fr)
ZW (1) ZW6284A1 (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0134984B1 (fr) * 1983-07-16 1988-07-13 Beecham Group Plc Dérivés de la benzazépine et de la benzoxazépine
GB9707251D0 (en) * 1997-04-10 1997-05-28 Smithkline Beecham Plc Novel method and compounds
ES2208310T3 (es) * 1999-03-31 2004-06-16 Vernalis Limited Derivados de pirimido(6,1-a) isoquinolin-4-ona.
US7169907B2 (en) * 2002-03-01 2007-01-30 Roche Diagnostics Operations, Inc. Derivatives, immunogens, and antibodies for detecting ecstasy-class drugs
US7501512B2 (en) * 2003-07-08 2009-03-10 Smithkline Beecham Corporation Chemical compounds
GB201502260D0 (en) 2015-02-11 2015-04-01 Verona Pharma Plc Salt of Pyrimido[6,1-A]Isoquinolin-4-one compound
WO2017016960A1 (fr) * 2015-07-24 2017-02-02 F. Hoffmann-La Roche Ag Procédé de préparation d'analogues de l'acide (6s)-6-alkyl-10-alcoxy-9-(alcoxy substitué)-2-oxo-6,7-dihydrobenzo[a]quinolizine-3-carboxylique
GB201613054D0 (en) 2016-07-28 2016-09-14 Verona Pharma Plc New compound and process
SI3822272T1 (sl) * 2018-07-13 2025-04-30 Chia Tai Tianqing Pharmaceutical Group Co., Ltd. Kondenzirana triciklična spojina kot dvojni inhibitor pde3/pde4
EP4643947A3 (fr) * 2020-01-15 2025-11-19 Chia Tai Tianqing Pharmaceutical Group Co., Ltd Cristal d'inhibiteur double de pde3/pde4 et son utilisation
AU2021208129A1 (en) * 2020-01-15 2022-08-18 Chia Tai Tianqing Pharmaceutical Group Co., Ltd. Pharmaceutical composition of tricyclic PDE3/PDE4 dual inhibitor compound

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ185900A (en) * 1976-12-10 1981-04-24 Hoechst Ag Pyrimido (6,1-a) isoquinolin-4-ones medicaments intermediate isoquinolines
DE2720085A1 (de) * 1977-05-05 1978-11-16 Hoechst Ag Pyrimido(6,1-a)isochinolin-2-on- derivate
FI64370C (fi) * 1977-05-05 1983-11-10 Hoechst Ag Foerfarande foer framstaellning av terapeutiskt anvaendbara pyimido-(6,1-a)isokinolin-2-imino-4-onderivat
DE2847693A1 (de) * 1978-11-03 1980-05-22 Hoechst Ag Verfahren zur herstellung von pyrimido-(6,1-a)-isochinolin-2-onen
DE3135831A1 (de) * 1981-09-10 1983-04-28 Hoechst Ag, 6230 Frankfurt 9,10-substituierte 2-mesitylimino-3-alkyl-3,4,6,7-tetrahydro-2h-pyrimido(6,1-a)isochinolin-4-one, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel

Also Published As

Publication number Publication date
HUT34025A (en) 1985-01-28
PT78549A (en) 1984-06-01
EP0124893A2 (fr) 1984-11-14
NZ207981A (en) 1987-05-29
DK198784D0 (da) 1984-04-17
EP0124893A3 (fr) 1987-11-11
PT78549B (en) 1986-09-15
MC1600A1 (fr) 1985-05-09
NO841780L (no) 1984-11-06
FI841619L (fi) 1984-11-06
FI841619A0 (fi) 1984-04-25
PH19219A (en) 1986-02-12
ES532172A0 (es) 1985-06-01
FI841619A7 (fi) 1984-11-06
DK198784A (da) 1984-11-06
CA1237429A (fr) 1988-05-31
ES8505369A1 (es) 1985-06-01
AU2751084A (en) 1984-11-08
US4581172A (en) 1986-04-08
IL71711A (en) 1987-08-31
ZW6284A1 (en) 1985-10-30
IL71711A0 (en) 1984-09-30
CS325584A2 (en) 1985-08-15

Similar Documents

Publication Publication Date Title
ES3030010T3 (en) Heterocyclic compounds as immunomodulators
TWI397530B (zh) 經取代的三唑并吡啶及其類似物
FI95377C (fi) Menetelmä terapeuttisesti aktiivisten pyrimidiinijohdannaisten valmistamiseksi
CN101516850B (zh) 适用作e1活化酶抑制剂的杂芳基化合物
DE69636671T2 (de) Pyrido[2,3-]-pyrimidine und deren Verwendung beim Inhibieren von Zellproliferation und Protein-Tyrosin-Kinase-Enzymaktivität
WO2018119236A1 (fr) Dérivés de triazolo[1,5-a]pyridine en tant qu'immunomodulateurs
KR20220161396A (ko) 치환된 피리디논-피리디닐 화합물의 제조, 조성물, 및 결정형
MX2014014112A (es) Nuevos compuestos.
WO2009029473A1 (fr) Composés tricycliques ayant une activité cytostatique et/ou cytotoxique et leurs procédés d'utilisation
MX2014004859A (es) Nuevos compuestos.
JPH02500518A (ja) 強心作用を有する化合物類
DK168046B1 (da) 2-substituerede cycloalkenooeeaaoe1,2,4aatriazolooe1,5-caapyrimidiner, deres tautomerer og farmaceutisk acceptable salte samt fremgangsmaade til fremstilling deraf
CS243486B2 (en) Method of new pyrimidine derivatives production
WO2017086832A1 (fr) N2-(4-amino-2-méthoxyphényl)-n4-[2-(diméthyl-phosphinoyl)phényl]-5-chlor-pirimidin-2,4-diamines substituées en tant que modulateurs d'alk et d'egfr destinés au traitement du cancer
WO1993016076A1 (fr) 3-(1H^_-TETRAZOL-5-YL)-4H^_-PYRIDO[1,2-a^_]PYRIMIDINE-4-ONES, COMPOSITIONS PHARMACEUTIQUES LES CONTENANT, ET LEUR PREPARATION
TW202408538A (zh) Stat降解劑及其用途
HU211149A9 (en) Pyridazinedione compounds
JP2023542419A (ja) 縮合環化合物及びその製造と使用
EA017117B1 (ru) 2-АМИНО-3-СУЛЬФОНИЛТЕТРАГИДРОПИРАЗОЛО[1,5-a]ПИРИДОПИРИМИДИНЫ - АНТАГОНИСТЫ СЕРОТОНИНОВЫХ 5-HT-РЕЦЕПТОРОВ, СПОСОБЫ ИХ ПОЛУЧЕНИЯ И ПРИМЕНЕНИЯ
ES2655177T3 (es) Diaminopirimidinas útiles como inhibidores del virus respiratorio sincitial (VRS) humano
CS220343B2 (en) Method of producing new imidazoquinazoline derivatives
PT85696B (pt) Processo para a preparacao de piridinas carbociclicas hetero {_f_} fundidas uteis como agentes dopaminergicos
KR102352637B1 (ko) 피리도[3,4-d]피리미딘 유도체 또는 그 용매화물의 결정
JP2021505580A (ja) ムスカリン性アセチルコリンレセプターm4のポジティブアロステリック調節因子
EP3098222B1 (fr) Dérivé d'acridine fondue et composition pharmaceutique, méthode de préparation et utilisation de celui-ci